Big biotech, Big pharma, Partnering, Pharma

Vectura in co development agreement with UCB for immunomodulatory product

Posted on 01 October 2013

Tags: , , , ,

Vectura Group have entered into a collaboration for the co development of an innovative biologic immunomodulatory product in the area of severe inflammatory respiratory disease.

The co development aims to leverage Vectura’s expertise in the pharmaceutical and clinical/regulatory development of inhaled therapeutics with UCB’s biologics and immunology assets.

The co development will focus on bringing to clinical proof-of-concept a UCB-generated biological therapy targeting a key molecule in the immune system.

The companies will jointly co manage the programme, with UCB focusing on bioprocess and preclinical development and Vectura taking responsibility for the pharmaceutical and clinical development of the dry powder product through to clinical proof-of-concept.

Financial terms of the co development partnership have not been disclosed.

For further deal information visit Current Agreements (subscription required)

Related

Read: more on UCB company profile, recent partnering, M&A and financing news and articles

Report: Partnering Deals and Alliances with UCB

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply